RBC Capital initiated coverage of Siemens Healthineers (SMMNY) with an Outperform rating and EUR 55 price target The firm says the stock’s valuation is not reflective of the company’s medium-term sales and earnings growth potential.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMNY:
- Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley
- Telix, Varian announce strategic collaboration to develop theranostics-EBRT
- Siemens Healthineers downgraded to Neutral from Outperform at BNPP
- Siemens Healthineers downgraded to Hold from Buy at Deutsche Bank
- Siemens Healthineers price target lowered to EUR 58 from EUR 62 at Citi